Medical Fluid Bag Market Set to Generate $6.05 billion, with a CAGR of 5.50% Globally, by 2028

June 19, 2025 11:03 AM BST | By EIN Presswire
 Medical Fluid Bag Market Set to Generate $6.05 billion, with a CAGR of 5.50% Globally, by 2028
Image source: EIN Presswire
These bags are typically composed of different polymers and include pockets for storing body fluids in a variety of biomedical procedures. ”
— Allied Market Research
PORTLAND, KS, UNITED STATES, June 19, 2025 /EINPresswire.com/ -- According to the report, the global fluid management devices industry was estimated at $4.56 billion in 2021, and is anticipated to hit $13.29 billion by 2031, registering a CAGR of 11.3% from 2022 to 2031.

Download Sample Report: https://www.alliedmarketresearch.com/request-sample/3526

A surge in the number of minimally invasive surgeries and the rise in the prevalence of chronic diseases such as endometrial cancer, bladder cancer, and gastrointestinal diseases which causes an increase in the application & usage of fluid management devices drives the global fluid management devices market. On the other hand, the high cost of minimally invasive surgeries such as laparoscopy impedes the market growth to some extent. However, a rise in the number of product launches and an increase in the number of key strategies by the major players are expected to pave the way for lucrative opportunities in the industry.

The fluid management systems segment to retain its dominance by 2031-

By product type, the fluid management systems segment accounted for the highest share in 2021, garnering more than half of the global fluid management devices market revenue. The same segment would also cite the fastest CAGR by 2031. A rise in the number of key players that manufacture powered fluid management devices and an increase in the number of product launches and product approvals for fluid management devices drive the segment growth.

The laparoscopy segment to rule the roost-

By application, the laparoscopy segment held the major share in 2021, generating nearly one-third of the global fluid management devices market revenue. Surge in the prevalence of chronic diseases such as cancer and rise in the number of key players that manufacture fluid management devices for laparoscopy propel the growth of the segment. The hysteroscopy segment, on the other hand, would portray the fastest CAGR of 11.9% from 2022 to 2031. The increase in the quantity of fluid management devices for hysteroscopy being introduced is responsible for the growth observed.

Procure Complete Report : https://www.alliedmarketresearch.com/checkout-final/fluid-management-devices-market

The hospitals segment to dominate by 2031–

By end-user, the hospitals segment accounted for more than two-thirds of the global fluid management devices market revenue in 2021, and is projected to rule the roost by 2031. The same segment would also portray the fastest CAGR of 11.5% from 2022 to 2031. The growth of this segment is being driven by two key factors: an increase in the number of surgical procedures being performed in hospitals, and a rise in government expenditure toward developing healthcare infrastructure.

North America garnered the major share in 2021 –

By region, North America generated more than one-third of the global fluid management devices market revenue in 2021, and is expected to dominate by 2031. The growth of the market across North America is driven by various factors such as the increasing number of manufacturers of fluid management devices, advancements in healthcare technology, and a rise in the prevalence of chronic diseases such as cancer. Asia-Pacific, however, would showcase the fastest CAGR of 12.1% from 2022 to 2031. The marker growth across Asia-Pacific is driven by factors such as increased government expenditure on healthcare, a rise in chronic illnesses, and a surge in the aging population.

Key players in the industry-

Olympus Corporation
Conmed corporation
Baxter international Inc.
Medtronic Plc.
Cardinal Health
Stryker Corporation
Karl Storz se and co. kg.
Bonvisi
Fresenius Medical Care
Hologic Inc.

Read More:

Urinary Incontinence Devices Market https://www.alliedmarketresearch.com/urinary-incontinence-devices-market

Dental Liners and Bases Market https://www.alliedmarketresearch.com/dental-liners-and-bases-market

Cancer Pain Market https://www.alliedmarketresearch.com/cancer-pain-market

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Market Research
+ 1800-792-5285
email us here
Visit us on social media:
LinkedIn
Facebook
YouTube
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next